RILP Antibody, FITC conjugated

Shipped with Ice Packs
In Stock

Description

Production and Conjugation Methodology

FITC conjugation to RILP antibodies involves covalent coupling of the fluorophore to primary amine groups (e.g., lysine residues) . Key steps include:

Optimal Conjugation Parameters

ParameterRecommended ValueRationale
FITC/Antibody Ratio3–6 FITC molecules/IgGHigher ratios reduce solubility and cause fluorescence quenching
pH9.5Enhances FITC reactivity with amines
TemperatureRoom temperature (25°C)Accelerates reaction kinetics
Reaction Time30–60 minutesAchieves maximal labeling efficiency without over-conjugation
PurificationGel filtration/columnRemoves unbound FITC and aggregates

Sodium azide must be removed pre-conjugation to prevent FITC inactivation . Commercial RILP antibodies (e.g., Proteintech’s 13574-1-AP or 82996-4-PBS) are often unconjugated but can be labeled in-house .

Applications in Research

RILP-FITC antibodies are used to study:

Lysosomal Dynamics and Autophagy

  • Rab7-RILP Interaction: FITC-conjugated RILP antibodies enable visualization of Rab7-RILP complexes during autophagosome-lysosome fusion .

  • Lysosome Localization: Co-localization studies with markers like LAMP1 or LC3 using FITC-RILP antibodies confirm lysosomal compartmentalization .

Immunofluorescence and Flow Cytometry

  • Cellular Staining: FITC-RILP antibodies detect endogenous RILP in permeabilized cells, with optimal dilutions typically 1:500–1:1000 .

  • Multiplex Imaging: Conjugation-ready RILP antibodies (e.g., 82996-4-PBS) allow custom FITC labeling for compatibility with other fluorophores .

Western Blotting (WB)

While FITC is not commonly used in WB, unconjugated RILP antibodies (e.g., ab140188) are validated for WB and immunoprecipitation (IP) .

Key Considerations

FactorImpact on Antibody PerformanceSource
FITC Labeling IndexHigher indices reduce binding affinity
Protein Concentration>1 mg/mL ensures efficient conjugation
Storage ConditionsLight protection; -20°C for stability

Case Study: In autophagy studies, IGF-I treatment restored Rab7-RILP interaction, detected via GST pull-down assays and immunoblotting . FITC-conjugated antibodies could enhance real-time visualization of this interaction.

Rab7-RILP Pathway Insights

  • Autophagy Regulation: Rab7-RILP interaction is critical for autophagosome-lysosome fusion; IGF-I/Akt signaling restores this interaction during trophic factor withdrawal .

  • Lysosomal Morphology: RILP depletion disrupts lysosome distribution, impairing cellular homeostasis .

Challenges in Conjugation

  • Quenching Effects: Excessive FITC labeling reduces fluorescence intensity and antibody solubility .

  • Batch Variability: Unoptimized conjugation ratios may yield inconsistent staining or background noise .

Product Specs

Buffer
Preservative: 0.03% ProClin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Product dispatch occurs within 1-3 business days of order receipt. Delivery times may vary depending on the order fulfillment method and destination. Please contact your local distributor for precise delivery estimates.
Synonyms
FLJ31193 antibody; PP10141 antibody; Rab interacting lysosomal protein antibody; Rab-interacting lysosomal protein antibody; Rilp antibody; RILP_HUMAN antibody
Target Names
RILP
Uniprot No.

Target Background

Function

Rab effector protein involved in late endocytic transport to lysosomes and other degradative compartments. It plays a crucial role in regulating lysosomal morphology and distribution. RILP induces the recruitment of dynein-dynactin motor complexes to Rab7A-positive late endosomes and lysosomes, facilitating the centripetal movement of phagosomes and their fusion with late endosomes and lysosomes.

Gene References Into Functions

RILP's function is implicated in several key processes. Research highlights its involvement in:

  • Hepatitis C Virus (HCV) Infection: HCV alters cellular trafficking by cleaving RILP, redirecting Rab7-containing vesicles to kinesin-dependent transport and enhancing virion secretion. PMID: 27791088
  • Breast Cancer Cell Invasion: RILP inhibits breast cancer cell invasion by interacting with RalGDS, suppressing its guanine nucleotide exchange factor activity for RalA. PMID: 26469971
  • Vacuolar ATPase Regulation: RILP regulates vacuolar ATPase activity through interaction with the V1G1 subunit. PMID: 26180254, PMID: 24762812
  • Interaction with the HOPS Complex: The VPS41 subunit of the HOPS complex is a major interacting partner of RILP. PMID: 25445562
  • Dynein Motor Interaction and Cholesterol Sensing: RILP interacts with both the HOPS complex and the p150(Glued) subunit of the dynein motor. ORP1L acts as a cholesterol-sensing switch, modulating these interactions. PMID: 23729732
  • Regulation of Lysosomal Morphology: A unique region within RILP is responsible for its role in regulating lysosomal morphology and its interaction with Rab7 and Rab34. PMID: 14668488
  • Rab7 Interaction: The crystal structure of the Rab7-RILP complex reveals specific interactions between Rab7 and RILP. PMID: 15933719
  • Self-Association: RILP exhibits self-association, likely forming homodimers. PMID: 15996637
  • Post-translational Modifications: RILP undergoes prenylation and phosphorylation at two protein kinase A sites. PMID: 16417580
  • Vesicle Fusion and Transport: RILP plays a role in regulating vesicle fusion and transport mediated by Rab7. PMID: 16631113
  • ESCRT-II Complex Interaction: RILP interacts with the EAP30/SNF8/VPS22 subunit of the ESCRT-II complex. PMID: 16857164
  • Multivesicular Endosome Biogenesis and EGFR Trafficking: RILP is required for multivesicular endosome biogenesis and the degradative trafficking of EGFRs. PMID: 17959629
  • REST/NRSF Nuclear Translocation: RILP forms a complex with REST/NRSF, dynactin p150(Glued), huntingtin, HAP1, involved in REST/NRSF nuclear translocation. PMID: 18922795
  • Late Endosome Positioning: ORP1L's interaction with VAP influences Rab7-RILP-p150 Glued interactions and late endosome positioning. PMID: 19564404
Database Links

HGNC: 30266

OMIM: 607848

KEGG: hsa:83547

STRING: 9606.ENSP00000301336

UniGene: Hs.534497

Subcellular Location
Late endosome membrane. Lysosome membrane. Cytoplasmic vesicle, phagosome membrane.
Tissue Specificity
Ubiquitous. Strongly expressed in fetal heart, heart, stomach, spleen, adrenal gland, thyroid gland, salivary gland, fetal liver, liver and lung. Poorly expressed in brain.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.